(HealthDay)—Many cancer patients hold unrealistic hopes when they decide to join early stage clinical trials of experimental treatments, new research shows.
Privately insured people with two types of cancer were diagnosed earlier and lived longer than those who were uninsured or were covered by Medicaid, according to two new studies.
Genetic testing of mitochondrial DNA could reveal otherwise unknown ancestry that can influence a person's risk for certain types of breast cancer, a new study finds.
(HealthDay)—Software that quickly analyzes mammograms and patient history to determine breast cancer risk could save time and reduce unnecessary biopsies, according to the developers of the technology.
In a first-of-its-kind study, researchers demonstrate a benefit in overall survival among epithelial ovarian cancer (EOC) patients receiving generic heart medications known as beta-blockers. Survival was shown to be greatest ...
(HealthDay)—Many teen girls with leukemia aren't checked for pregnancy before they receive chemotherapy drugs that can cause birth defects, a new study finds.
Researchers at Houston Methodist have developed an artificial intelligence (AI) software that reliably interprets mammograms, assisting doctors with a quick and accurate prediction of breast cancer risk. According to a new ...
A new analysis indicates that rates of high-grade cervical lesions decreased in young U.S. women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes ...
(HealthDay)—An intervention involving bilingual/bicultural lay health educator (LHE) education can increase colorectal cancer (CRC) screening among Hmong-Americans, according to a study published online Aug. 26 in Cancer.
(HealthDay)—Tyrosine kinase inhibitors (TKIs) appear to be safe in patients with chronic-phase (CP) chronic myeloid leukemia (CML) and chronic kidney disease (CKD), according to a study published online July 28 in Cancer.